VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DSSDSS, Inc.
$0.54$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

DSS logoDSS, Inc.(DSS)Earnings, Financials & Key Ratios

DSS•AMEX
$0.56
Price updated Jun 25, 2026
SectorConsumer CyclicalIndustryPackagingSub-IndustryPaperboard, Corrugated and Cartons
AboutDSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged in—nonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.Show more
  • Revenue$21M+8.7%
  • EBITDA-$11M+39.2%
  • Net Income-$24M+49.0%
  • EPS (Diluted)-2.66+59.9%
  • Gross Margin-10.45%+55.1%
  • EBITDA Margin-52.53%+44.1%
  • Operating Margin-69.54%+36.6%
  • Net Margin-115.28%+53.1%
  • ROE-115.51%-42.8%

DSS Price & Volume

DSS, Inc. (DSS) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Threaten Corporate Solvency

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Decelerating
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Persistent negative gross margins
"DSS, Inc. faces a precarious outlook as its fragmented conglomerate model struggles to generate positive gross margins, which plummeted to -27.8% in 2026Q1. The company's reliance on debt financing has pushed the debt-to-equity ratio to 4.94 as of 2025Q4, while the rapid erosion of its equity base to a negative $832,000 suggests significant long-term structural instability. Investors should remain cautious as the firm's inability to achieve consistent free cash flow, evidenced by a -126.5% FCF margin in 2025Q3, continues to jeopardize its liquidity and operational viability."

Verdict Logic

the company's fundamental health is severely compromised by a negative equity base of $832,000 and a current ratio of only 0.22, indicating extreme insolvency risk.

DSS Growth Metrics

DSS, Inc. (DSS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.72%
5 Years6.2%
3 Years-9.9%
TTM-0.22%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM47.45%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM59%

Return on Capital

10 Years-19.48%
5 Years-24.43%
3 Years-31.44%
Last Year-46.89%

DSS Recent Earnings

DSS, Inc. (DSS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (25%)●Beat Revenue 1/12 qtrs (17%)
Q2 2026Latest
May 15, 2026
Metric
Actual
Est
EPS
$0.60-57.9%
$0.38
Rev
$4M-19.1%
$5M
Q2 2026
Mar 31, 2026
Metric
Actual
Est
EPS
$1.63
—
Rev
$4M
—
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$0.25
—
Rev
$6M
—
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$0.17
—
Rev
$5M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 15, 2026
$0.60vs $0.38-57.9%
$4Mvs $5M-19.1%
Q2 2026Mar 31, 2026
$1.63
$4M
Q4 2025Nov 14, 2025
$0.25
$6M
Q3 2025Aug 14, 2025
$0.17
$5M
Based on last 12 quarters of dataView full earnings history →

Peers Comparison

Key metrics vs top competitors for DSS, Inc. (DSS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
DSS logoDSSDSS, Inc.Current
$0.56$4.73M-0.218.69%-115.28%-115.51%—
CODA logoCODACoda Octopus Group, Inc.
$9.43$106.38M25.4930.75%17.66%8.33%—
AEYE logoAEYEAudioEye, Inc.
$5.98$74.71M-23.9214.52%-9.05%-70.95%—
NXRT logoNXRTNexPoint Residential Trust, Inc.
$27.31$693.08M-21.67-3.24%-12.67%-10.13%—
AMRK logoAMRKA-Mark Precious Metals, Inc.
$46.72$1.16B65.8013.19%0.08%1.78%—
SGBX logoSGBXSafe & Green Holdings Corp.
$0.96$32.96K-0.00-69.88%-569.09%-134.41%—

Compare DSS vs Peers

DSS, Inc. (DSS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CODA

Most directly comparable listed peer for DSS.

Scale Benchmark

vs MARA

Larger-name benchmark to compare DSS against a more recognizable public peer.

Peer Set

Compare Top 5

vs CODA, AEYE, NXRT, AMRK

DSS SEC Filings & Documents

DSS, Inc. (DSS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 31, 2026·SEC

Material company update

Feb 5, 2026·SEC

Material company update

Dec 5, 2025·SEC

10-K Annual Reports

4
FY 2026

Mar 31, 2026·SEC

FY 2025

Mar 31, 2025·SEC

FY 2024

Mar 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 15, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 14, 2025·SEC

Get notified when DSS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

DSS Frequently Asked Questions

DSS, Inc. (DSS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is DSS, Inc.'s revenue?

DSS, Inc. (DSS) reported $20.1M in revenue for fiscal year 2025. This represents a 77503% increase from $0.0M in 1997.

How fast is DSS, Inc. growing?

DSS, Inc. (DSS) grew revenue by 8.7% over the past year. This is steady growth.

Is DSS profitable?

DSS, Inc. (DSS) reported a net loss of $25.0M for fiscal year 2025.

Dividend & Returns
What is DSS's return on equity?

DSS, Inc. (DSS) has a return on equity (ROE) of -115.5%. Negative ROE indicates the company is unprofitable.

What is DSS, Inc.'s free cash flow?

DSS, Inc. (DSS) had negative free cash flow of $8.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in DSS back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →